Facebook
Twitter
Telegram
Report an ErrorTalis Biomedical Corporation Financial Statements 2011-2024 | TLIS
Annual Financial Statements Talis Biomedical Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
15.9 M | 990 K | 66.8 M | - | - | - | - | - | - | - | - | - | - |
Shares |
1.82 M | 1.8 M | 22.7 M | - | - | - | - | - | - | - | - | - | - |
Historical Prices |
8.75 | 0.55 | 2.95 | - | - | - | - | - | - | - | - | - | - |
Net Income |
-62 M | -113 M | -192 M | - | -27.5 M | -21.3 M | - | - | - | - | - | - | - |
Revenue |
2.13 M | 4.81 M | 8.19 M | 10.9 M | 3.98 M | 2.39 M | - | - | - | - | - | - | - |
Cost of Revenue |
41 K | 8.39 M | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 10.9 M | - | - | - | - | - | - | - | - | - |
Operating Income |
-66.8 M | -115 M | -192 M | -91.2 M | - | - | - | - | - | - | - | - | - |
Interest Expense |
4.81 M | 2.13 M | -220 K | 54 K | - | - | - | - | - | - | - | - | - |
EBITDA |
-66 M | -106 M | -190 M | -90.4 M | -26 M | -20.8 M | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | 102 M | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
28.2 M | 40.7 M | 42.4 M | 13.1 M | 6.86 M | 5.43 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Talis Biomedical Corporation
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
1.82 M | 1.82 M | 1.82 M | 1.82 M | 1.81 M | 1.81 M | 1.8 M | 1.8 M | 26.5 M | 26.4 M | 25.8 M | 25.6 M | 13.1 M | 2.13 M | 2.12 M | 2.12 M | 2.12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-13 M | - | -15.7 M | -15 M | -17.8 M | - | -26 M | -27 M | -33.1 M | - | -38.4 M | -64.5 M | -60.5 M | - | -29.5 M | -10 M | -7.37 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
73 K | - | 140 K | 581 K | 1.22 M | - | 796 K | 572 K | 3.19 M | - | 218 K | - | 7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
6 K | - | 6 K | 7 K | 20 K | - | 1.24 M | 1.3 M | 3.52 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | -440 K | - | -334 K | - | 218 K | - | 7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-14.1 M | - | -17 M | -16.4 M | -19 M | - | -26.8 M | -27.3 M | -33 M | - | -38.4 M | -64.4 M | -60.5 M | - | -29.6 M | -10 M | -7.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
1.08 M | - | 1.29 M | 1.36 M | 1.17 M | - | 765 K | 262 K | -84 K | - | -3 K | - | 28 K | - | 69 K | - | 21 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-13.9 M | - | - | - | -18.8 M | - | -21.5 M | -27.3 M | -32.6 M | - | -37.8 M | -64.4 M | -60.3 M | - | -29 M | -9.65 M | -7.21 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | 26.3 M | - | 32.6 M | - | 38.6 M | 64.5 M | 67.5 M | - | 39.1 M | 10.8 M | 7.79 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
11.7 M | - | 8.8 M | 6.41 M | 6.4 M | - | 8.82 M | 9.18 M | 11.9 M | - | 12.8 M | 9.98 M | 7.33 M | - | 3.06 M | 2.66 M | 2.08 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency